Structure Therapeutics, Inc. (GPCR)
43.23
+1.70
(+4.09%)
USD |
NASDAQ |
Jun 11, 16:00
43.23
0.00 (0.00%)
After-Hours: 18:14
Structure Therapeutics Total Assets (Quarterly) : 1.508B for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 1.508B |
| December 31, 2025 | 1.584B |
| September 30, 2025 | 832.16M |
| June 30, 2025 | 816.46M |
| March 31, 2025 | 866.56M |
| December 31, 2024 | 903.33M |
| September 30, 2024 | 933.22M |
| June 30, 2024 | 947.05M |
| March 31, 2024 | 457.22M |
| Date | Value |
|---|---|
| December 31, 2023 | 482.02M |
| September 30, 2023 | 216.37M |
| June 30, 2023 | 229.42M |
| March 31, 2023 | 247.35M |
| December 31, 2022 | 97.85M |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | 111.15M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Eli Lilly & Co. | 116.58B |
| Novo Nordisk A/S | 86.23B |
| Viking Therapeutics, Inc. | 608.24M |
| Pfizer Inc. | 207.62B |
| Tarsus Pharmaceuticals, Inc. | 581.14M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 61.03M |
| Shareholders Equity (Quarterly) | 1.447B |
| Debt to Equity Ratio | 0.004 |
| Current Ratio | 26.16 |
| Net Debt Paydown Yield | -0.01% |